The Company's BLA for pz-cel was previously accepted for Priority Review by the FDA for patients with RDEB. Abeona may be ...

The Food and Drug Administration (FDA) has accepted for review the resubmitted Biologics License Application (BLA) for prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis ...

Fraternal twins tend to run in families. Researchers think there may be a gene for hyperovulation (the tendency to release ...

Abeona Therapeutics (ABEO) announced the FDA has accepted for review resubmission of Biologics License Application for prademagene ...

Fisher, R A. 1930. The Genetical Theory of Natural Selection Clarendon Press, Oxford.

Learn about the most beautiful and sought-after blue cats. From fluffy to short haired and everything in between, you'll love ...

aDepartment of Neurology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, USA bUCLA Ataxia Center, University of California at Los Angeles, Los Angeles, ...

Data from Eloxx's proof-of-concept trial in patients with nonsense mutation Alport Syndrome (NMAS) presented in late-breaking presentation at America ...

Saudi researchers from Qassim University identified Bethlem Myopathy, a rare genetic disorder. The scientific discovery sheds ...

Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript November 4, 2024 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9. Operator: Thank ...

In the case of this particular elk, she is brown and white, with the white appearing on her face and shoulders. Piebaldism is ...